"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 12 | 18 | 30 |
| 1997 | 15 | 37 | 52 |
| 1998 | 23 | 23 | 46 |
| 1999 | 22 | 48 | 70 |
| 2000 | 19 | 53 | 72 |
| 2001 | 21 | 48 | 69 |
| 2002 | 21 | 62 | 83 |
| 2003 | 32 | 65 | 97 |
| 2004 | 30 | 68 | 98 |
| 2005 | 31 | 85 | 116 |
| 2006 | 26 | 81 | 107 |
| 2007 | 41 | 82 | 123 |
| 2008 | 36 | 65 | 101 |
| 2009 | 39 | 70 | 109 |
| 2010 | 27 | 73 | 100 |
| 2011 | 39 | 98 | 137 |
| 2012 | 44 | 81 | 125 |
| 2013 | 37 | 100 | 137 |
| 2014 | 70 | 108 | 178 |
| 2015 | 76 | 112 | 188 |
| 2016 | 80 | 100 | 180 |
| 2017 | 76 | 136 | 212 |
| 2018 | 75 | 135 | 210 |
| 2019 | 65 | 130 | 195 |
| 2020 | 44 | 166 | 210 |
| 2021 | 42 | 133 | 175 |
| 2022 | 4 | 129 | 133 |
| 2023 | 3 | 106 | 109 |
| 2024 | 34 | 90 | 124 |
| 2025 | 33 | 99 | 132 |
| 2026 | 7 | 43 | 50 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Divergent biology and outcomes of somatic transformations in germ cell tumors. Oncologist. 2026 Jul 08; 31(8).
-
Genetics of Cerebrotendinous Xanthomatosis. Mol Diagn Ther. 2026 Jul; 30(4):681-687.
-
Biomarker study of pembrolizumab in patients with advanced rare cancers. Cell Rep Med. 2026 Jun 16; 7(6):102827.
-
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets. Nat Cancer. 2026 Jun; 7(6):993-1015.
-
Single-nucleus profiling reveals a core disease signature and cell type-specific vulnerabilities in early Rett syndrome. Sci Adv. 2026 Jun 12; 12(24):eaeb4265.
-
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy. Nat Commun. 2026 May 30; 17(1).
-
Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly. Am J Hum Genet. 2026 Jun 04; 113(6):1214-1232.
-
Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk. Nat Commun. 2026 May 21; 17(1).
-
H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs. Nat Genet. 2026 Jun; 58(6):1368-1382.
-
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy. Clin Cancer Res. 2026 May 15; 32(10):2079-2087.